Brachytherapy for oligometastatic prostate cancer to the penis

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis. We present the case of a 61-year-old patient who developed a penile induration 7 years after radical prostatectomy followed by adjuvant external beam radiation therapy for high-risk prostatic adenocarcinoma. Biopsies confirmed the metastatic localization and a detailed assessment failed to find any further remote lesions. Faced with this penile oligometastatic prostate cancer, we proposed an ablative treatment based on interstitial multi-catheter high-dose rate brachytherapy. At the six-month follow-up, clinical examination and 68Ga-PSMA-11-PET confirmed a complete response of the penile tumor without new lesion at a distance.

Cite

CITATION STYLE

APA

Martz, N., Benziane-Ouaritini, N., Gautier, M., Brenot-Rossi, I., Montagne, L., Salem, N., … Hannoun-Levi, J. M. (2021). Brachytherapy for oligometastatic prostate cancer to the penis. Journal of Contemporary Brachytherapy, 13(5), 593–597. https://doi.org/10.5114/jcb.2021.109754

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free